Recovery

October 17, 2024 | First Responders, Harm Reduction, Model Laws, Naloxone, Opioid Antagonists, Opioid Antagonists, Recovery, Substance Abuse, Treatments

The key elements of the Model Overdose Reversal Agents Act are to: (1) remove all existing restrictions about who can receive, possess, store, transfer without cost, or administer an ORA such that any “person or entity” is eligible; (2) require specified individuals and entities to offer ORAs to individuals at increased risk of overdose; (3) require emergency access to ORAs at specified locations for use by any individual; (4) provide guidelines for ORA sales, in particular sales of non-prescription ORAs; (6) grant broad immunity to people or entities for prescribing, dispensing, giving, donating, transferring without charge, selling, or administering ORAs in the absence of gross negligence, malice, or criminal intent; (7) identify the required content for educational information about ORAs and specify when that information must be disseminated; (8) require Medicaid and other health insurance coverage for ORAs, including non-prescription ORAs, and prohibit discriminatory life and health insurance practices; and (9) create a bulk overdose reversal agent purchasing fund to assist persons and entities to fulfill requirements under the Act....

October 2, 2024 | Harm Reduction, Innovative Initiatives, Naloxone, Opioid Antagonists, Opioid Antagonists, Recovery, Substance Abuse

Paramedics in the State of New Jersey are permitted to carry and administer buprenorphine to treat acute withdrawal symptoms after having had an opioid overdose reversed with naloxone. The directive, via Executive Order from the State Health Commissioner, simply added buprenorphine to the list of medications available to paramedics in the MICUs and required officials in each county to train paramedics on the protocol. ...

September 26, 2024 | Criminal Justice, Medication Assisted Treatment (MAT), Model Laws, Recovery, Treatments

Drafted in partnership with the O'Neill Institute for National and Global Health Law at Georgetown University, the purpose of the this model legislation is to: (1) promote the use of all U.S. Food and Drug Administration-approved medication for addiction treatment options in correctional settings; (2) ensure that all incarcerated individuals with a substance use disorder are provided access to medication for addiction treatment while incarcerated, are treated as individual patients, and have individualized treatment plans reflecting their clinical needs and not a one-size-fits-all approach; and (3) ensure that, upon release from a correctional setting, individuals receiving medication for addiction treatment are provided with a connection in the community for continued care, including a prescription for the medication for addiction treatment and the necessary contacts and tools to continue their treatment....

September 25, 2024 | Criminal Justice, Legal & Legislative Research, Recovery, Reentry

Collateral consequences are legal, regulatory, and policy barriers imposed against an individual arrested for, charged with, or convicted of a criminal offense that often have no connection to the criminal offense. In this document, LAPPA (1) provides a single resource highlighting each jurisdiction’s laws related to collateral consequences; (2) allows for comparison of the laws between jurisdictions; and (3) identifies and highlights any interesting or novel provisions....

September 24, 2024 | Controlled Substances, Criminal Justice, Harm Reduction, Law Enforcement, Opioids, Prescription Drugs, Public Health, Public Safety, Recovery, Substance Abuse, Toolkits

The Legislative Analysis and Public Policy Association (LAPPA), in partnership with the Institute for Intergovernmental Relations, developed several resources related to overdose fatality review (OFR), including a complete summary of state OFR laws, a guide on how OFR teams can obtain information from the Indian Health Service, and a guide on how OFR teams can obtain information from the Veterans Health Administration....

July 12, 2024 | Fact Sheets, Medication Assisted Treatment (MAT), Novel Psychoactive Substances, Opioids, Recovery, Substance Abuse, Treatments

In this fact sheet the Legislative Analysis and Public Policy Association (LAPPA) details the changes to the "primary diagnosis other than OUD" regulation. The fact sheet also covers the federal regulatory scheme for methadone for OUD and explains what led SAMHSA to revise its regulations. ...

May 22, 2024 | Medication Assisted Treatment (MAT), Model Laws, Pharmacy, Recovery, Treatments

The Model Pharmacist Collaboration for Medication for Opioid Use Disorder Act, drafted in collaboration with the Center for Health Law Studies at the St. Louis University School of Law, can help to save the lives and improve the health and quality of life of individuals who have an opioid use disorder (OUD) by expanding access to and availability of medication for OUD....

May 12, 2024 | Emergency Departments, First Responders, Harm Reduction, Innovative Initiatives, Medication Assisted Treatment (MAT), Opioid Antagonists, Opioid Antagonists, Opioids, Public Health, Recovery, Substance Abuse, Treatments

Paramedics in the State of New Jersey are permitted to carry and administer buprenorphine to treat acute withdrawal symptoms after having had an opioid overdose reversed with naloxone. The directive, via Executive Order from the State Health Commissioner, simply added buprenorphine to the list of medications available to paramedics in the MICUs and required officials in each county to train paramedics on the protocol. ...

April 11, 2024 | Controlled Substances, Criminal Justice, Harm Reduction, Medication Assisted Treatment (MAT), Naloxone, Opioid Antagonists, Opioids, Prescription Drugs, Public Health, Public Safety, Recovery, Reports & Studies, Substance Abuse, Treatments

The Addiction and Public Policy Initiative at the O’Neill Institute for National and Global Health Law was established in 2018 through a generous grant from Arnold Ventures. Housed at Georgetown Law, the Addiction and Public Policy Initiative works at the intersection of public health and the law to advance a public health approach to substance use disorder and the overdose epidemic through legal and policy strategies that promote evidence-based treatment, harm reduction, and recovery. This reports highlights O'Neill's accomplishments over the last five years....

April 9, 2024 | Emergency Departments, First Responders, Innovative Initiatives, Medication Assisted Treatment (MAT), Opioids, Public Health, Recovery, Substance Abuse, Treatments

The Coordinated Opioid Recovery (CORE) Network, overseen by the Florida Department of Health, the Florida Department of Children and Families, and the Florida Agency for Health Care Administration establishes a system of care for individuals suffering from substance use disorder (SUD). CORE provides a state-supported, coordinated system of addiction care for individuals with SUD and has provided approximately 550,000 services to support patients since its inception in 2022....